IP International Journal of Aesthetic and Health Rejuvenation

---

Elevation of troponin T and N-terminal pro-B-type natriuretic peptide (nt- pro BNP) in heart failure patients with CKD

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Shaik Mahmood*

Volume : 2, Issue : 2, Year : 2019

Article Page : 26-29

Suggest article by email

---

Abstract

Elevation of Troponin T and N-Terminal pro-B-type natriuretic peptide (NT-proBNP) are commonly and strongly predictable biomarkers of Heart Failure (HF) patients with CKD. The present study included 150 people with CKD. We examined the association of baseline levels of elevation of TnT and NT-pro BNP with Heart Failure (HF) and CKD patients, after the adjustment for demographic factors, traditional cardiovascular risk factors and biomarkers of Chronic Kidney Disease. Constant medication application and mineral metabolism biomarkers cause Heart Failure and CKD. At base line, elevation of TnT levels ranged from <_5.0 to 1000 pg/ml and NT-proBNP levels ranged from <_5.0 to 35000 pg/ml. Compared to normal controls for TnT <_5.8 – 25.8 pg/ml and NT_proBNP 54 – 340 pg/ml.
With this conclusion the elevation of TnT and NT-prBNP were strongly associated with incident of Heart Failure (HF) among with severe CKD. Elevations in these biomarkers may indicate subclinical changes in volume and myocardial stress that subsequently contribute to clinical Heart Failure (HF) with CKD.

Keywords: Cardiovascular disease, Heart failure, Kidney disease, Troponin T and N-Terminal pro-B-type natriuretic peptide (NT-proBNP).

How to cite : Mahmood S, Elevation of troponin T and N-terminal pro-B-type natriuretic peptide (nt- pro BNP) in heart failure patients with CKD. Int J Aesthet Health Rejuvenation 2019;2(2):26-29

Copyright © 2019 by author(s) and Int J Aesthet Health Rejuvenation. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)